Biogen Inc.
Location
Massachusetts
Founded
1978-02-28
Website
Risk Signals
6605 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations, Biological Products, Except Diagnostic Substances, Commercial Physical and Biological Research), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Biogen Inc.
Live alerts from global media, monitored by Business Radar
2024-06-12 (wpcomstaging.com)
Biogen Remote Jobs Customer Support Jobs
Biogen Remote Jobs Customer Support Jobs, Biogen Work From Home Jobs Advisor Full Time, Biogen Support Member Jobs
Read more2024-02-09 (labiotech.eu)
Biotech job market 2024: what to expect?
The past year saw pipeline cuts and downsizing plans strike the biotech industry. Does the biotech job market seem to be looking up this year?
Read more2023-10-13 (dallasnews.com)
Mass layoffs in Texas: 20,000 jobs eliminated this year
Nine other Texas companies announced job cuts between now and the end of the year
Read more2023-08-22 (nzz.ch)
Biotech: Biogen employees in Baar are worried about their job
The drug manufacturer Biogen is cutting more than every ninth job worldwide. Since functions within the headquarters are to disappear in advance, fear is raging at the international headquarters.
Read more2023-07-25 (biospace.com)
Biogen to Cut 1,000 Jobs as Part of $1B Cost Savings Plan | BioSpace
The biotech’s “Fit for Growth” program, which includes the headcount reduction, is expected to generate a net savings of $700 million on operating expenses by 2025.
Read more2023-07-25 (cnbc.com)
Biogen to cut 1,000 jobs to save costs as company prepares for Leqembi launch
Biogen, in its second-quarter earnings report, said the plan will result in $700 million in net operating expense savings by 2025.
Read more2023-07-25 (reuters.com)
Biogen announces job cuts, turns focus to Alzheimer's drug launch
Biogen Inc said on Tuesday it expects to slash about 1,000 jobs, or 11% of its workforce, in a fresh round of cost-cutting as it looks to the launch of a new Alzheimer's drug to help it return to growth.
Read more2023-04-11 (dnyuz.com)
Biogen Lays Off More Employees Months After Slashing 900 Jobs
Massachusetts-based biotechnology company Biogen Inc. has cut more jobs to overcome surging losses, with employees who worked on its multiple
Read more2020-06-10 (bioprocessintl.com)
Fujifilm invests $928m to double capacity at ex-Biogen plant, adding 300 jobs
Fujifilm will increase bioreactor capacity to 240,000 L at the recently acquired site in Denmark, feeding the high demand for biomanufacturing services.
Read more